NEW YORK, NY / ACCESSWIRE / December 22, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Pep Boys-Manny Moe and Jack (NYSE: PBY), Changyou.Com Ltd. (NASDAQ: CYOU), Rewalk Robotics Ltd. (NASDAQ: RWLK) and Aveo Pharmaceuticals Inc. (NASDAQ: AVEO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
PBY Research Package: http://www.traders-choice.com/pdf?s=PBY
CYOU Research Package: http://www.traders-choice.com/pdf?s=CYOU
RWLK Research Package: http://www.traders-choice.com/pdf?s=RWLK
AVEO Research Package: http://www.traders-choice.com/pdf?s=AVEO
============
Highlights from today's reports include:
On Monday, December 21, 2015, the NASDAQ Composite ended at 4,968.92, up 0.93%, the Dow Jones Industrial Average advanced 0.72%, to finish the day at 17,251.62, and the S&P 500 closed at 2,021.15, up 0.78%.
- Pep Boys-Manny Moe and Jack's stock edged higher by 6.92% to close Monday's session at USD 16.85. The company's shares oscillated between USD 16.51 and USD 16.85 in trade during the day. The stock recorded a trading volume of 0.94 million shares, which was below its 50-day daily average volume of 1.64 million shares but above its 52-week average volume of 0.68 million shares. Over the last three days Pep Boys-Manny Moe and Jack's shares have advanced 4.98% and in the past one week the stock has moved up 4.01%. Furthermore, over the last three months the stock has gained 39.03% and in the past six months the shares have picked up 44.39%. The stock is trading at a price to book ratio of 1.56 which compares to a historical PB ratio close to 0.86. Additionally, the stock is trading at a price to cash flow ratio of 12.86 and price to sales ratio of 0.41.
- The stock of Changyou.Com Ltd. gained 5.80% to close Monday's session at USD 25.00. The shares of the company moved in the range of USD 23.65 and USD 25.37 during the day. A trading volume of 0.88 million shares was recorded, which was greater than its 150-day daily average volume of 0.19 million shares and its 52-week average volume of 0.18 million shares. Over the last five days Changyou.Com Ltd.'s shares have advanced 25.57% and in the past one month the stock has gained a momentum of 15.21%. Additionally, over the last three months the stock has advanced 28.21% while in the past six months the shares have registered a loss of 18.62%. Further, the company is trading at a price to earnings ratio of 7.12 and a price to book ratio of 1.25. Further, the shares are trading at a price to cash flow ratio of 5.07 and price to sales ratio of 0.51.
- Rewalk Robotics Ltd.'s stock increased by 0.81% to close Monday's session at USD 13.61. The company's shares fluctuated in the range of USD 13.30 and USD 15.45 during the day. A total of 2.99 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.42 million shares and was above its 52-week average volume of 0.17 million shares. Over the last three days Rewalk Robotics Ltd.'s shares have advanced 126.83% and in the past one week the stock has moved up 133.45%. Furthermore, over the last three months, the stock has gained 45.95% and in the past six months, the shares have picked up 15.53%. The stock has been exhibiting some positive momentum and is trading above its 50-day and 200-day simple moving averages by 70.99% and 33.56%, respectively. Additionally, the stock has a Relative Strength Index of 83.47.
- Aveo Pharmaceuticals Inc.'s stock added 22.33% to close Monday's session at USD 1.26. The company's shares oscillated between USD 1.20 and USD 1.42 in trade during the day. The stock recorded a trading volume of 10.45 million shares, which was above its 50-day daily average volume of 0.60 million shares and its 52-week average volume of 1.71 million shares. Over the last five days Aveo Pharmaceuticals Inc.'s shares have advanced 28.57% and in the past one month the stock has gained a momentum of 10.53%. However, over the last three months the stock has lost 9.35% while year to date the shares have picked up 49.96%. The stock is trading at a price to book ratio of 2.51 which compares to a historical PB ratio close to 2.13. Additionally, the shares are trading at a price to sales ratio of 3.86.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
